Astrazeneca

FromAstraZeneca ([email protected])
Subject (74)Calquence tablet formulation approved in the US across current indications
Preheader (74)Calquence tablet formulation approved in the US across current indications
Typography
Arial
Colors
Text Analysis
Body Words210
Subject Words10
Body Emojis1
Subject Emojis
Media Analysis
Text Links8
Image Links4
Total Links12
Images7
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px762 px
X-Spam Score0.4
Preheader OptimizedNo
Timing
Day of WeekWednesday
TimeEarly Morning

Calquence tablet formulation approved in the US across current indications

Calquence tablet formulation approved in the US across current indications
Calquence tablet formulation approved in the US across current indications